跳至主要内容
临床试验/NCT05456334
NCT05456334进行中(未招募)不适用

New Treatments for Actinic Keratoses of the Scalp

Helsinki University Central Hospital0 个研究点目标入组 120 人开始时间: 2016年3月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120
主要终点
Lesion-specific clearance (%, P)

研究概览

简要总结

This blinded controlled 2-year study on 120 patients with 2 or more actinic keratoses, compare the efficacy and tolerability of pulsed dye-laser- mediated photodynamic therapy compared to conventional photodynamic therapy and fractional-laser assisted daylight photodynamic therapy compared to daylight photodynamic therapy.

详细描述

Actinic keratoses are premalign skin lesions with increasing prevalence, causing a rising burden on the health care system. In this blinded controlled study we assess the efficacy of pulsed dye-laser- mediated photodynamic therapy compared to conventional photodynamic therapy and fractional-laser assisted daylight photodynamic therapy to daylight photodynamic therapy. It is a prospective, randomized and blinded split-head comparative study during the years 2016- 2024. 120 patients are recruited based on referral or from patients attending the clinic, with 2 or more actinic keratoses on the head, 60 to the pulsed dye-laser study and 60 to the fractional laser study. Follow-up appointments are 6 months, 1 year and 2 years post treatment. Patient reported maximal pain during treatment is documented.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • at least 2 AKs located on both sides of the head (either the scalp, forehead, temples, or cheeks)

排除标准

  • pigmented AKs, in situ-carcinomas, skin cancers, psoriasis or eczema on the treatment area

研究组 & 干预措施

Pulsed dye laser-mediated photodynamic therapy

Experimental

After curretage light-sensitizer (methyl aminolaevulinate cream) was applied on the lesions and covered with an occlusive plastic foil for 2-3-h incubation. Then a local lidocaine anaesthetic spray was applied. The lesions were illuminated with 30% overlapping pulsed laser double-stacked pulses (, energy 7 J/cm2, spot size 7 mm, pulse duration 10 ms, wavelength 595 nm and dynamic cooling 2/3).

干预措施: Pulsed-dye laser (Device)

Pulsed dye laser-mediated photodynamic therapy

Experimental

After curretage light-sensitizer (methyl aminolaevulinate cream) was applied on the lesions and covered with an occlusive plastic foil for 2-3-h incubation. Then a local lidocaine anaesthetic spray was applied. The lesions were illuminated with 30% overlapping pulsed laser double-stacked pulses (, energy 7 J/cm2, spot size 7 mm, pulse duration 10 ms, wavelength 595 nm and dynamic cooling 2/3).

干预措施: Metvix cream (Drug)

Conventional photodynamic therapy

Active Comparator

After curretage a light-sensitizer (methyl aminolaevulinate cream) was applied on the lesions and covered with an occlusive plastic foil for 2-3-h incubation. Then a local lidocaine anaesthetic spray was applied. The lesions were illuminated with a red LED light for 7-8 min (exposure 75 J/cm2, wavelength 630 nm).

干预措施: Metvix cream (Drug)

Ablative fractional laser- mediated daylight photodynamic therapy

Experimental

After curretage lidocaine anaesthetic spray was applied on the whole treatment area. Lesions were treated with an ablative fractional CO2-laser (19 W, Dot mode, spacing 1000 µm, stack 3, scanning dwell time 1800 µs, repeat 0.5 s). A thin layer of light sensitizer (methyl aminolaevulinate cream) was applied on the treatment area. The patients were asked to move outdoors (temperature >10C, no rain, June-August) or to our adPDT-room (IndoorLux®, wavelength 350-750 nm, 15-25 000 lux) within 30 minutes, for the 2h-illumination.

干预措施: Fractional CO2-laser (Device)

Ablative fractional laser- mediated daylight photodynamic therapy

Experimental

After curretage lidocaine anaesthetic spray was applied on the whole treatment area. Lesions were treated with an ablative fractional CO2-laser (19 W, Dot mode, spacing 1000 µm, stack 3, scanning dwell time 1800 µs, repeat 0.5 s). A thin layer of light sensitizer (methyl aminolaevulinate cream) was applied on the treatment area. The patients were asked to move outdoors (temperature >10C, no rain, June-August) or to our adPDT-room (IndoorLux®, wavelength 350-750 nm, 15-25 000 lux) within 30 minutes, for the 2h-illumination.

干预措施: Metvix cream (Drug)

Daylight photodynamic therapy

Active Comparator

After curretage lidocaine anaesthetic spray was applied on the whole treatment area. A thin layer of light sensitizer (methyl aminolaevulinate cream) was applied on the treatment area. The patients were asked to move outdoors (temperature >10C, no rain, June-August) or to our adPDT-room (IndoorLux®, wavelength 350-750 nm, 15-25 000 lux) within 30 minutes, for the 2h-illumination.

干预措施: Metvix cream (Drug)

结局指标

主要结局

Lesion-specific clearance (%, P)

时间窗: 2 year

Proportion of lesions that completely healed, partially healed or not healed in the particular treatment

Patient complete (%, P) or partial clearance (%, P)

时间窗: 2 year

All actinic keratoses on the particular treatment area cleared, or 75% of lesions on treatment area cleared

次要结局

  • Patient reported pain(1 day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kirsi Isoherranen

Principal investigator

Helsinki University Central Hospital

相似试验